| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | peptidyltransferase activity | 6.79e-06 | 6 | 141 | 3 | GO:0000048 | |
| GeneOntologyMolecularFunction | leukotriene-C(4) hydrolase | 6.79e-06 | 6 | 141 | 3 | GO:0002951 | |
| GeneOntologyMolecularFunction | leukotriene C4 gamma-glutamyl transferase activity | 1.88e-05 | 8 | 141 | 3 | GO:0103068 | |
| GeneOntologyMolecularFunction | glutathione hydrolase activity | 2.81e-05 | 9 | 141 | 3 | GO:0036374 | |
| GeneOntologyMolecularFunction | omega peptidase activity | 1.80e-04 | 16 | 141 | 3 | GO:0008242 | |
| GeneOntologyMolecularFunction | threonine-type peptidase activity | 3.60e-04 | 20 | 141 | 3 | GO:0070003 | |
| GeneOntologyBiologicalProcess | homophilic cell adhesion via plasma membrane adhesion molecules | CHL1 FAT4 DSCAM PCDHGA7 CDHR1 PCDHB2 PCDHA4 PCDHA1 DSCAML1 TENM3 PVR CDH5 PCDH18 | 5.29e-10 | 187 | 141 | 13 | GO:0007156 |
| GeneOntologyBiologicalProcess | cell-cell adhesion via plasma-membrane adhesion molecules | CHL1 FAT4 DSCAM PCDHGA7 CDHR1 PCDHB2 PCDHA4 PCDHA1 DSCAML1 PTPRD TENM3 PVR CDH5 PCDH18 | 3.29e-08 | 313 | 141 | 14 | GO:0098742 |
| GeneOntologyBiologicalProcess | glutathione catabolic process | 6.65e-07 | 11 | 141 | 4 | GO:0006751 | |
| GeneOntologyBiologicalProcess | leukotriene D4 metabolic process | 9.93e-07 | 12 | 141 | 4 | GO:1901748 | |
| GeneOntologyBiologicalProcess | cell morphogenesis | CHL1 ABI1 NRDC DSCAM FGD2 CDHR1 SRF SPART LHX3 CUL7 DSCAML1 AR RYK KIAA0319 FAM171A1 SHROOM1 DLC1 PTPRD NFIX ANAPC2 CD44 DOCK7 CDH5 | 6.17e-06 | 1194 | 141 | 23 | GO:0000902 |
| GeneOntologyBiologicalProcess | sulfur amino acid metabolic process | 7.55e-06 | 40 | 141 | 5 | GO:0000096 | |
| GeneOntologyBiologicalProcess | cysteine biosynthetic process | 1.71e-05 | 8 | 141 | 3 | GO:0019344 | |
| GeneOntologyBiologicalProcess | peptide modification | 3.62e-05 | 10 | 141 | 3 | GO:0031179 | |
| GeneOntologyBiologicalProcess | leukotriene D4 biosynthetic process | 3.62e-05 | 10 | 141 | 3 | GO:1901750 | |
| GeneOntologyBiologicalProcess | cell morphogenesis involved in neuron differentiation | CHL1 ABI1 NRDC DSCAM CDHR1 SRF SPART LHX3 CUL7 DSCAML1 RYK KIAA0319 PTPRD NFIX ANAPC2 DOCK7 | 5.40e-05 | 748 | 141 | 16 | GO:0048667 |
| GeneOntologyBiologicalProcess | modified amino acid catabolic process | 1.16e-04 | 37 | 141 | 4 | GO:0042219 | |
| GeneOntologyBiologicalProcess | exit from mitosis | 1.16e-04 | 37 | 141 | 4 | GO:0010458 | |
| GeneOntologyBiologicalProcess | cell-cell adhesion | CHL1 IL12RB1 FAT4 DSCAM PCDHGA7 CDHR1 ADAM9 SRF PCDHB2 PCDHA4 PCDHA1 PTAFR DSCAML1 PTPRD TENM3 PVR CD44 CDH5 PCDH18 | 1.38e-04 | 1077 | 141 | 19 | GO:0098609 |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection morphogenesis | CHL1 ABI1 NRDC DSCAM SRF SPART LHX3 CUL7 DSCAML1 RYK KIAA0319 PTPRD NFIX ANAPC2 CD44 DOCK7 | 1.55e-04 | 819 | 141 | 16 | GO:0120039 |
| GeneOntologyBiologicalProcess | cysteine metabolic process | 1.64e-04 | 16 | 141 | 3 | GO:0006534 | |
| GeneOntologyBiologicalProcess | cell projection morphogenesis | CHL1 ABI1 NRDC DSCAM SRF SPART LHX3 CUL7 DSCAML1 RYK KIAA0319 PTPRD NFIX ANAPC2 CD44 DOCK7 | 1.70e-04 | 826 | 141 | 16 | GO:0048858 |
| GeneOntologyBiologicalProcess | leukotriene metabolic process | 1.74e-04 | 41 | 141 | 4 | GO:0006691 | |
| GeneOntologyBiologicalProcess | regulation of extent of cell growth | 1.94e-04 | 122 | 141 | 6 | GO:0061387 | |
| GeneOntologyBiologicalProcess | fatty acid derivative metabolic process | 2.49e-04 | 82 | 141 | 5 | GO:1901568 | |
| GeneOntologyBiologicalProcess | positive regulation of molecular function | TRADD ABI1 FGD2 ADAM9 LARS1 SRF CAT CNPY2 CDC14B AR RYK TFDP1 CEMIP RTKN2 STAC2 TTBK1 DLC1 DOCK7 AIM2 ENO1 MMUT CCS | 2.81e-04 | 1430 | 141 | 22 | GO:0044093 |
| GeneOntologyBiologicalProcess | glutathione biosynthetic process | 3.27e-04 | 20 | 141 | 3 | GO:0006750 | |
| GeneOntologyBiologicalProcess | regulation of axonogenesis | 3.59e-04 | 192 | 141 | 7 | GO:0050770 | |
| GeneOntologyBiologicalProcess | sulfur amino acid biosynthetic process | 3.80e-04 | 21 | 141 | 3 | GO:0000097 | |
| GeneOntologyBiologicalProcess | neuron development | CHL1 FAT4 ABI1 NRDC DSCAM CDHR1 SRF ARFGEF1 SPART LHX3 CUL7 DSCAML1 RYK KIAA0319 PTPRD TENM3 NFIX ANAPC2 CD44 DOCK7 RP1 VPS13B | 3.85e-04 | 1463 | 141 | 22 | GO:0048666 |
| GeneOntologyBiologicalProcess | neuron projection morphogenesis | CHL1 ABI1 NRDC DSCAM SRF SPART LHX3 CUL7 DSCAML1 RYK KIAA0319 PTPRD NFIX ANAPC2 DOCK7 | 3.98e-04 | 802 | 141 | 15 | GO:0048812 |
| GeneOntologyBiologicalProcess | nonribosomal peptide biosynthetic process | 4.38e-04 | 22 | 141 | 3 | GO:0019184 | |
| GeneOntologyBiologicalProcess | leukotriene biosynthetic process | 4.38e-04 | 22 | 141 | 3 | GO:0019370 | |
| GeneOntologyBiologicalProcess | fatty acid derivative biosynthetic process | 4.39e-04 | 52 | 141 | 4 | GO:1901570 | |
| GeneOntologyBiologicalProcess | neuron projection development | CHL1 FAT4 ABI1 NRDC DSCAM SRF ARFGEF1 SPART LHX3 CUL7 DSCAML1 RYK KIAA0319 PTPRD TENM3 NFIX ANAPC2 CD44 DOCK7 VPS13B | 4.71e-04 | 1285 | 141 | 20 | GO:0031175 |
| GeneOntologyBiologicalProcess | sulfur compound catabolic process | 4.73e-04 | 53 | 141 | 4 | GO:0044273 | |
| GeneOntologyBiologicalProcess | anatomical structure homeostasis | 4.95e-04 | 334 | 141 | 9 | GO:0060249 | |
| GeneOntologyBiologicalProcess | tissue homeostasis | 4.95e-04 | 334 | 141 | 9 | GO:0001894 | |
| GeneOntologyBiologicalProcess | axonogenesis | CHL1 NRDC DSCAM SRF SPART LHX3 DSCAML1 RYK KIAA0319 NFIX ANAPC2 DOCK7 | 5.21e-04 | 566 | 141 | 12 | GO:0007409 |
| HumanPheno | Irregular dentition | 1.74e-05 | 6 | 50 | 3 | HP:0040079 | |
| MousePheno | abnormal circulating glutathione level | 5.08e-06 | 5 | 113 | 3 | MP:0030652 | |
| MousePheno | increased circulating glutathione level | 5.08e-06 | 5 | 113 | 3 | MP:0030653 | |
| MousePheno | glutathionuria | 5.08e-06 | 5 | 113 | 3 | MP:0013730 | |
| MousePheno | increased glutathione level | 5.08e-06 | 5 | 113 | 3 | MP:0012606 | |
| MousePheno | decreased circulating cysteine level | 1.76e-05 | 7 | 113 | 3 | MP:0030626 | |
| MousePheno | decreased follicle stimulating hormone level | 2.67e-05 | 44 | 113 | 5 | MP:0005130 | |
| MousePheno | decreased cysteine level | 2.80e-05 | 8 | 113 | 3 | MP:0030623 | |
| MousePheno | epididymis hypoplasia | 2.80e-05 | 8 | 113 | 3 | MP:0004932 | |
| MousePheno | nervous | 4.17e-05 | 9 | 113 | 3 | MP:0008912 | |
| MousePheno | failure of copulatory plug deposition | 5.92e-05 | 10 | 113 | 3 | MP:0030983 | |
| MousePheno | seminal vesicle hypoplasia | 5.92e-05 | 10 | 113 | 3 | MP:0005148 | |
| MousePheno | ovary hypoplasia | 5.92e-05 | 10 | 113 | 3 | MP:0005158 | |
| MousePheno | aciduria | 7.96e-05 | 55 | 113 | 5 | MP:0010028 | |
| MousePheno | abnormal circulating cysteine level | 8.10e-05 | 11 | 113 | 3 | MP:0030624 | |
| MousePheno | absent tertiary ovarian follicles | 8.10e-05 | 11 | 113 | 3 | MP:0011130 | |
| MousePheno | decreased circulating gonadotropin level | 1.21e-04 | 60 | 113 | 5 | MP:0003363 | |
| MousePheno | abnormal cysteine level | 1.39e-04 | 13 | 113 | 3 | MP:0030621 | |
| MousePheno | decreased glutathione level | 1.39e-04 | 13 | 113 | 3 | MP:0012604 | |
| MousePheno | abnormal glutathione level | 1.39e-04 | 13 | 113 | 3 | MP:0012603 | |
| MousePheno | decreased circulating follicle stimulating hormone level | 1.56e-04 | 34 | 113 | 4 | MP:0002790 | |
| MousePheno | priapism | 1.75e-04 | 14 | 113 | 3 | MP:0003415 | |
| MousePheno | thick retina inner plexiform layer | 1.93e-04 | 3 | 113 | 2 | MP:0014265 | |
| MousePheno | small epididymis | 2.52e-04 | 70 | 113 | 5 | MP:0004930 | |
| MousePheno | abnormal copulatory plug deposition | 2.67e-04 | 16 | 113 | 3 | MP:0030982 | |
| MousePheno | decreased spleen red pulp amount | 2.67e-04 | 16 | 113 | 3 | MP:0008477 | |
| MousePheno | abnormal circulating insulin-like growth factor I level | 2.87e-04 | 72 | 113 | 5 | MP:0004700 | |
| MousePheno | abnormal insulin-like growth factor I level | 3.47e-04 | 75 | 113 | 5 | MP:0008831 | |
| MousePheno | induced hyperactivity | 3.58e-04 | 42 | 113 | 4 | MP:0008911 | |
| MousePheno | failure of superovulation | 3.84e-04 | 18 | 113 | 3 | MP:0031422 | |
| MousePheno | abnormal penile erection | 3.84e-04 | 18 | 113 | 3 | MP:0001379 | |
| MousePheno | oocyte degeneration | 3.84e-04 | 18 | 113 | 3 | MP:0009093 | |
| MousePheno | increased spleen neoplasm incidence | 3.85e-04 | 4 | 113 | 2 | MP:0005649 | |
| MousePheno | increased circulating growth hormone level | 4.53e-04 | 19 | 113 | 3 | MP:0005123 | |
| MousePheno | abnormal copulation physiology | 4.53e-04 | 19 | 113 | 3 | MP:0031627 | |
| MousePheno | kyphosis | 5.37e-04 | 229 | 113 | 8 | MP:0000160 | |
| MousePheno | enlarged lateral ventricles | 5.87e-04 | 84 | 113 | 5 | MP:0008535 | |
| MousePheno | small vertebrae | 7.08e-04 | 22 | 113 | 3 | MP:0004610 | |
| MousePheno | decreased thyroxine level | 7.55e-04 | 51 | 113 | 4 | MP:0005471 | |
| MousePheno | decreased circulating pituitary hormone level | 7.64e-04 | 89 | 113 | 5 | MP:0005118 | |
| MousePheno | abnormal follicle stimulating hormone level | 7.64e-04 | 89 | 113 | 5 | MP:0003967 | |
| MousePheno | increased growth hormone level | 8.10e-04 | 23 | 113 | 3 | MP:0005137 | |
| MousePheno | uterus hypoplasia | 8.10e-04 | 23 | 113 | 3 | MP:0001121 | |
| MousePheno | abnormal copulation behavior | 9.20e-04 | 24 | 113 | 3 | MP:0009697 | |
| MousePheno | narrow head | 9.51e-04 | 6 | 113 | 2 | MP:0003742 | |
| Domain | Cadherin | FAT4 PCDHGA7 CDHR1 PCDHB2 PCDHA4 PCDHA1 KIAA0319 CDH5 PCDH18 | 2.43e-07 | 118 | 139 | 9 | IPR002126 |
| Domain | Cadherin_CS | 1.55e-06 | 109 | 139 | 8 | IPR020894 | |
| Domain | CADHERIN_1 | 2.04e-06 | 113 | 139 | 8 | PS00232 | |
| Domain | Cadherin | 2.04e-06 | 113 | 139 | 8 | PF00028 | |
| Domain | CADHERIN_2 | 2.18e-06 | 114 | 139 | 8 | PS50268 | |
| Domain | - | 2.18e-06 | 114 | 139 | 8 | 2.60.40.60 | |
| Domain | CA | 2.33e-06 | 115 | 139 | 8 | SM00112 | |
| Domain | Cadherin-like | 2.48e-06 | 116 | 139 | 8 | IPR015919 | |
| Domain | Cadherin_2 | 1.23e-04 | 65 | 139 | 5 | PF08266 | |
| Domain | Cadherin_N | 1.23e-04 | 65 | 139 | 5 | IPR013164 | |
| Domain | FYrich_C | 5.42e-04 | 5 | 139 | 2 | IPR003889 | |
| Domain | FYrich_N | 5.42e-04 | 5 | 139 | 2 | IPR003888 | |
| Domain | FYRC | 5.42e-04 | 5 | 139 | 2 | SM00542 | |
| Domain | FYRN | 5.42e-04 | 5 | 139 | 2 | SM00541 | |
| Domain | FYRN | 5.42e-04 | 5 | 139 | 2 | PF05964 | |
| Domain | FYRC | 5.42e-04 | 5 | 139 | 2 | PF05965 | |
| Domain | FYRC | 5.42e-04 | 5 | 139 | 2 | PS51543 | |
| Domain | FYRN | 5.42e-04 | 5 | 139 | 2 | PS51542 | |
| Pathway | WP_EICOSANOID_SYNTHESIS | 2.56e-05 | 22 | 113 | 4 | MM15961 | |
| Pathway | WP_OXYLIPINS_PATHWAYS | 3.67e-05 | 24 | 113 | 4 | MM17249 | |
| Pathway | REACTOME_SYNTHESIS_OF_LEUKOTRIENES_LT_AND_EOXINS_EX | 4.35e-05 | 25 | 113 | 4 | MM14858 | |
| Pathway | REACTOME_AFLATOXIN_ACTIVATION_AND_DETOXIFICATION | 5.11e-05 | 26 | 113 | 4 | MM15190 | |
| Pathway | WP_EICOSANOID_METABOLISM_VIA_LIPOXYGENASES_LOX | 1.34e-04 | 33 | 113 | 4 | MM15963 | |
| Pathway | REACTOME_GLUTATHIONE_SYNTHESIS_AND_RECYCLING | 2.60e-04 | 16 | 113 | 3 | MM14680 | |
| Pubmed | 3.86e-09 | 6 | 141 | 4 | 8663190 | ||
| Pubmed | Different gamma-glutamyl transpeptidase mRNAs are expressed in human liver and kidney. | 6.52e-08 | 3 | 141 | 3 | 2573352 | |
| Pubmed | 6.48e-07 | 5 | 141 | 3 | 23615310 | ||
| Pubmed | 6.48e-07 | 5 | 141 | 3 | 11003618 | ||
| Pubmed | 6.48e-07 | 5 | 141 | 3 | 10392451 | ||
| Pubmed | 6.48e-07 | 5 | 141 | 3 | 19850887 | ||
| Pubmed | Reversible skeletal abnormalities in gamma-glutamyl transpeptidase-deficient mice. | 6.48e-07 | 5 | 141 | 3 | 12810527 | |
| Pubmed | Growth retardation and cysteine deficiency in gamma-glutamyl transpeptidase-deficient mice. | 6.48e-07 | 5 | 141 | 3 | 8755578 | |
| Pubmed | Reproductive defects in gamma-glutamyl transpeptidase-deficient mice. | 6.48e-07 | 5 | 141 | 3 | 11089562 | |
| Pubmed | 6.48e-07 | 5 | 141 | 3 | 26977590 | ||
| Pubmed | Gamma-glutamyl transferase deficiency results in lung oxidant stress in normoxia. | 6.48e-07 | 5 | 141 | 3 | 12225953 | |
| Pubmed | 6.48e-07 | 5 | 141 | 3 | 7775425 | ||
| Pubmed | 6.48e-07 | 5 | 141 | 3 | 9139708 | ||
| Pubmed | 6.48e-07 | 5 | 141 | 3 | 20622017 | ||
| Pubmed | Accelerated methylmercury elimination in gamma-glutamyl transpeptidase-deficient mice. | 6.48e-07 | 5 | 141 | 3 | 9546365 | |
| Pubmed | 6.48e-07 | 5 | 141 | 3 | 7485380 | ||
| Pubmed | Accumulation of DNA damage in the organs of mice deficient in gamma-glutamyltranspeptidase. | 6.48e-07 | 5 | 141 | 3 | 10751614 | |
| Pubmed | Type VI RNA is the major gamma-glutamyl transpeptidase RNA in the mouse small intestine. | 6.48e-07 | 5 | 141 | 3 | 7523374 | |
| Pubmed | Cardio-reno-hepatic interactions in acute heart failure: the role of γ-glutamyl transferase. | 6.48e-07 | 5 | 141 | 3 | 24698228 | |
| Pubmed | 6.48e-07 | 5 | 141 | 3 | 10474818 | ||
| Pubmed | Lung lining fluid glutathione attenuates IL-13-induced asthma. | 6.48e-07 | 5 | 141 | 3 | 18063838 | |
| Pubmed | 6.48e-07 | 5 | 141 | 3 | 10940879 | ||
| Pubmed | Cataract development in gamma-glutamyl transpeptidase-deficient mice. | 6.48e-07 | 5 | 141 | 3 | 11095909 | |
| Pubmed | 6.48e-07 | 5 | 141 | 3 | 7641802 | ||
| Pubmed | 6.48e-07 | 5 | 141 | 3 | 9627710 | ||
| Pubmed | 6.48e-07 | 5 | 141 | 3 | 12453183 | ||
| Pubmed | 6.48e-07 | 5 | 141 | 3 | 2891746 | ||
| Pubmed | 6.48e-07 | 5 | 141 | 3 | 28660214 | ||
| Pubmed | Bleomycin-induced pulmonary fibrosis is attenuated in gamma-glutamyl transpeptidase-deficient mice. | 6.48e-07 | 5 | 141 | 3 | 12468440 | |
| Pubmed | Cloning of cDNA and genomic structure of the mouse gamma-glutamyl transpeptidase-encoding gene. | 6.48e-07 | 5 | 141 | 3 | 8566783 | |
| Pubmed | 6.48e-07 | 5 | 141 | 3 | 30591459 | ||
| Pubmed | 6.48e-07 | 5 | 141 | 3 | 11795900 | ||
| Pubmed | Inhibiting lung lining fluid glutathione metabolism with GGsTop as a novel treatment for asthma. | 6.48e-07 | 5 | 141 | 3 | 25132819 | |
| Pubmed | Characterization of the dwg mutations: dwg and dwg(Bayer) are new mutant alleles of the Ggt1 gene. | 6.48e-07 | 5 | 141 | 3 | 19760322 | |
| Pubmed | 1.29e-06 | 6 | 141 | 3 | 14634009 | ||
| Pubmed | Six mRNAs with different 5' ends are encoded by a single gamma-glutamyltransferase gene in mouse. | 1.29e-06 | 6 | 141 | 3 | 8101000 | |
| Pubmed | Mapping of human gamma-glutamyl transpeptidase genes on chromosome 22 and other human autosomes. | 1.29e-06 | 6 | 141 | 3 | 8104871 | |
| Pubmed | 1.29e-06 | 6 | 141 | 3 | 11463821 | ||
| Pubmed | 1.29e-06 | 6 | 141 | 3 | 25326709 | ||
| Pubmed | 1.29e-06 | 6 | 141 | 3 | 12163373 | ||
| Pubmed | 1.29e-06 | 6 | 141 | 3 | 22242126 | ||
| Pubmed | 1.29e-06 | 6 | 141 | 3 | 17363454 | ||
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | ACACA STXBP4 LARS1 SPART KIF4A SRCAP NPLOC4 HNRNPH1 CCNT1 GTF2A1 GTF2I PDLIM3 PRRC2C KMT2A ENO1 AHNAK2 | 1.36e-06 | 934 | 141 | 16 | 33916271 |
| Pubmed | 1.62e-06 | 268 | 141 | 9 | 33640491 | ||
| Pubmed | AMFR HYOU1 ACACA SPART TARS2 HNRNPH1 GTF2I PRRC2C DOCK7 ENO1 MMUT STOML2 | 2.01e-06 | 534 | 141 | 12 | 35032548 | |
| Pubmed | Transcriptional profiling and therapeutic targeting of oxidative stress in neuroinflammation. | 2.26e-06 | 7 | 141 | 3 | 32284594 | |
| Pubmed | 2.26e-06 | 7 | 141 | 3 | 36685533 | ||
| Pubmed | 2.26e-06 | 7 | 141 | 3 | 27775020 | ||
| Pubmed | Defective epidermal growth factor gene expression in mice with polycystic kidney disease. | 2.26e-06 | 7 | 141 | 3 | 1968405 | |
| Pubmed | ACACA KIF4A POGZ SRCAP MIDEAS TAB3 KMT2C GTF2I PRRC2C DOCK7 KMT2A ENO1 | 2.68e-06 | 549 | 141 | 12 | 38280479 | |
| Pubmed | KNTC1 KIAA0586 CUL7 TUBGCP5 USP20 ANO8 PCF11 TSC22D1 TTBK1 DHTKD1 PCDH18 | 5.84e-06 | 493 | 141 | 11 | 15368895 | |
| Pubmed | 7.67e-06 | 10 | 141 | 3 | 23863468 | ||
| Pubmed | ABI1 DSCAM ADAM9 HECTD4 WDR81 KIF4A ARHGEF11 KIAA0319 FAM171A1 PTPRD PRRC2C NISCH DOCK7 ENO1 STOML2 | 9.25e-06 | 963 | 141 | 15 | 28671696 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | ENGASE ACACA INTS1 HECTD4 SRCAP ARHGEF11 CDC14B ANO8 KMT2C KANSL1 NEK8 NISCH CTDP1 AP1G2 SUFU AHNAK2 | 1.13e-05 | 1105 | 141 | 16 | 35748872 |
| Pubmed | Cadherin superfamily genes: functions, genomic organization, and neurologic diversity. | 1.31e-05 | 74 | 141 | 5 | 10817752 | |
| Pubmed | HYOU1 ACACA INTS1 KIF4A POGZ CUL7 GTF2I PRRC2C DOCK7 KMT2A MVP STOML2 | 1.53e-05 | 653 | 141 | 12 | 22586326 | |
| Pubmed | 1.59e-05 | 77 | 141 | 5 | 10835267 | ||
| Pubmed | 1.63e-05 | 2 | 141 | 2 | 31996681 | ||
| Pubmed | 1.63e-05 | 2 | 141 | 2 | 25180444 | ||
| Pubmed | 1.63e-05 | 2 | 141 | 2 | 15623502 | ||
| Pubmed | 1.63e-05 | 2 | 141 | 2 | 17332502 | ||
| Pubmed | 1.63e-05 | 2 | 141 | 2 | 9694699 | ||
| Pubmed | 1.63e-05 | 2 | 141 | 2 | 21645617 | ||
| Pubmed | 1.63e-05 | 2 | 141 | 2 | 25280803 | ||
| Pubmed | 1.63e-05 | 2 | 141 | 2 | 24553346 | ||
| Pubmed | Receptors for hyaluronic acid and poliovirus: a combinatorial role in glioma invasion? | 1.63e-05 | 2 | 141 | 2 | 22363471 | |
| Pubmed | 1.63e-05 | 2 | 141 | 2 | 12547160 | ||
| Pubmed | Generation of the tumor-suppressive secretome from tumor cells. | 1.63e-05 | 2 | 141 | 2 | 34373756 | |
| Pubmed | 1.63e-05 | 2 | 141 | 2 | 25451118 | ||
| Pubmed | 1.63e-05 | 2 | 141 | 2 | 37904480 | ||
| Pubmed | Mammalian DSCAMs: roles in the development of the spinal cord, cortex, and cerebellum? | 1.63e-05 | 2 | 141 | 2 | 12051741 | |
| Pubmed | 1.63e-05 | 2 | 141 | 2 | 23682772 | ||
| Pubmed | 1.63e-05 | 2 | 141 | 2 | 29204984 | ||
| Pubmed | 1.63e-05 | 2 | 141 | 2 | 17342749 | ||
| Pubmed | 1.63e-05 | 2 | 141 | 2 | 31796514 | ||
| Pubmed | Large exons encoding multiple ectodomains are a characteristic feature of protocadherin genes. | 1.92e-05 | 80 | 141 | 5 | 10716726 | |
| Pubmed | LIN54 LARS1 LHX3 POGZ CUL7 SRCAP MIDEAS TFDP1 TAB3 PCF11 KMT2C GTF2I KANSL1 PRRC2C NFIX ZKSCAN3 KMT2A SUFU | 2.03e-05 | 1429 | 141 | 18 | 35140242 | |
| Pubmed | 2.30e-05 | 14 | 141 | 3 | 18357469 | ||
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | HYOU1 ACACA LARS1 WDR81 SRCAP HNRNPH1 RTKN2 PDLIM3 KMT2A ENO1 CCDC9 STOML2 AHNAK2 | 2.66e-05 | 807 | 141 | 13 | 30575818 |
| Pubmed | 2.83e-05 | 43 | 141 | 4 | 33472061 | ||
| Pubmed | 3.13e-05 | 298 | 141 | 8 | 30737378 | ||
| Pubmed | 4.53e-05 | 407 | 141 | 9 | 12693553 | ||
| Pubmed | 4.88e-05 | 3 | 141 | 2 | 20200161 | ||
| Pubmed | 4.88e-05 | 3 | 141 | 2 | 23932714 | ||
| Pubmed | 4.88e-05 | 3 | 141 | 2 | 24425872 | ||
| Pubmed | 4.88e-05 | 3 | 141 | 2 | 20432434 | ||
| Pubmed | 4.88e-05 | 3 | 141 | 2 | 27637097 | ||
| Pubmed | 4.88e-05 | 3 | 141 | 2 | 15791001 | ||
| Pubmed | 4.88e-05 | 3 | 141 | 2 | 12082086 | ||
| Pubmed | An improved Flp deleter mouse in C57Bl/6 based on Flpo recombinase. | 4.88e-05 | 3 | 141 | 2 | 20506501 | |
| Pubmed | Intracellular effect of imidazoline receptor on alpha(2A)-noradrenergic receptor. | 4.88e-05 | 3 | 141 | 2 | 15028622 | |
| Pubmed | 4.88e-05 | 3 | 141 | 2 | 17975004 | ||
| Pubmed | Identification of fat4 and tsc22d1 as novel candidate genes for spontaneous pulmonary adenomas. | 4.88e-05 | 3 | 141 | 2 | 21764761 | |
| Pubmed | 4.88e-05 | 3 | 141 | 2 | 9334314 | ||
| Pubmed | Gene dosage in the developing and adult brain in a mouse model of 22q11 deletion syndrome. | 5.09e-05 | 18 | 141 | 3 | 17097888 | |
| Pubmed | 7.09e-05 | 170 | 141 | 6 | 36470425 | ||
| Pubmed | HYOU1 NRDC ADAM9 TARS2 NPLOC4 CEMIP PRRC2C NISCH ANAPC2 DOCK7 KMT2A | 7.33e-05 | 650 | 141 | 11 | 38777146 | |
| Pubmed | FAT4 ACACA DSCAM LIN54 PCDHB2 ARFGEF1 KIF4A PCF11 GTF2I TENM3 CD44 DOCK7 | 8.18e-05 | 777 | 141 | 12 | 35844135 | |
| Pubmed | 8.22e-05 | 21 | 141 | 3 | 15328023 | ||
| Pubmed | Clustered gamma-protocadherins regulate cortical interneuron programmed cell death. | 8.65e-05 | 57 | 141 | 4 | 32633719 | |
| Interaction | NFIX interactions | LIN54 SRF POGZ SRCAP MIDEAS AR TFDP1 HNRNPH1 KMT2C NFIX KMT2A ENO1 | 5.03e-08 | 227 | 137 | 12 | int:NFIX |
| Interaction | RYK interactions | FAT4 ABI1 PCDHGA7 CDHR1 PCDHB2 RYK FAM171A1 PTPRD PVR CDH5 PCDH18 | 2.24e-07 | 212 | 137 | 11 | int:RYK |
| Interaction | PCDHGB1 interactions | 1.41e-05 | 77 | 137 | 6 | int:PCDHGB1 | |
| Interaction | GGT1 interactions | 2.31e-05 | 25 | 137 | 4 | int:GGT1 | |
| GeneFamily | CD molecules|Gamma-glutamyltransferases | 3.18e-05 | 13 | 89 | 3 | 564 | |
| GeneFamily | Clustered protocadherins | 2.78e-04 | 64 | 89 | 4 | 20 | |
| GeneFamily | Fibronectin type III domain containing | 1.16e-03 | 160 | 89 | 5 | 555 | |
| ToppCell | LPS-IL1RA+antiTNF-Myeloid-Monocytes,_Macrophages-Erythroid|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.46e-07 | 155 | 141 | 7 | 4559e3011514041b65c17ae4ede29da202bce14c | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_Arw_fibro_(16)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.18e-06 | 186 | 141 | 7 | 4d68ee3d32f7ef884faf402ef92b31b0eb4656f1 | |
| ToppCell | COVID-19-kidney-Fibroblast-1|kidney / Disease (COVID-19 only), tissue and cell type | 3.41e-06 | 199 | 141 | 7 | 9503646ff1ad248181146ce767e9d12e882ec3bd | |
| ToppCell | Hippocampus-Endothelial-MURAL|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 1.13e-05 | 158 | 141 | 6 | 2d73b5e59c650c603fec6223b1c51f0962f7bc81 | |
| ToppCell | Hippocampus-Endothelial-MURAL-M1(Rgs5Acta2)|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 1.13e-05 | 158 | 141 | 6 | 7f4a644534b78f7e7539cae1fd895dad6f96862b | |
| ToppCell | E18.5-Immune-Immune_Myeloid-DC-cDC2|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.60e-05 | 168 | 141 | 6 | 93b7138f17aa14a6398c9b4ea7237781a0e19a66 | |
| ToppCell | E18.5-Immune-Immune_Myeloid-DC-cDC2-cDC2_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.60e-05 | 168 | 141 | 6 | e393553208617a023f1646169c892a87c95db3f5 | |
| ToppCell | droplet-Pancreas-Exocrine-24m-Epithelial|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.60e-05 | 168 | 141 | 6 | 100ab6d36592b61f4db9f8cb90c48afac016d679 | |
| ToppCell | droplet-Pancreas-Exocrine-24m-Epithelial-pancreatic_ductal_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.02e-05 | 175 | 141 | 6 | 6bb8fc2959583644f16b22e906af91af62a3a633 | |
| ToppCell | droplet-Pancreas-Exocrine-24m-Epithelial-pancreatic_ductal_cel|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.02e-05 | 175 | 141 | 6 | 8902c38067f025b094ca9c28c449c32a66eded1c | |
| ToppCell | pdx-Tumor_cells-T0|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 2.76e-05 | 185 | 141 | 6 | 1d874608aa2062024323512f68889219471b2f00 | |
| ToppCell | PBMC-Convalescent-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_3|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.11e-05 | 189 | 141 | 6 | a2f4f1dd5452f7efb7427919a0b90875cf2e1dc7 | |
| ToppCell | PBMC-Convalescent-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_3|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.11e-05 | 189 | 141 | 6 | 54a45b0cb7dea01caf1cf0a2664c40e5779a0b61 | |
| ToppCell | 10x_3'_v3-bone_marrow_(10x_3'_v3)-hematologic-erythrocytic-erythrocyte|bone_marrow_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.49e-05 | 193 | 141 | 6 | 305e15ee467826ee08b2617c69f250ad39c11b19 | |
| ToppCell | 10x_3'_v3-bone_marrow_(10x_3'_v3)-hematologic-erythrocytic|bone_marrow_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.49e-05 | 193 | 141 | 6 | dd376664906caccc9c2065f8e7a364509e18a5cc | |
| ToppCell | 10x5'v1-week_17-19-Mesenchymal_osteo-stroma-osteoblast_precursor|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 3.81e-05 | 196 | 141 | 6 | 57df2a57b35be9851ac0b1e5731baa53052511f0 | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_adipo-stroma-adipo-CAR|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 4.03e-05 | 198 | 141 | 6 | a8c21f4db6730d0aa05b61fbe72bf9f7571a9015 | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_adipo-stroma|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 4.03e-05 | 198 | 141 | 6 | 8b68fc887e5ad0a59ea4d93dfd1edda67030f142 | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_adipo|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 4.03e-05 | 198 | 141 | 6 | 4739b2e4ab141c66772e61686b45614a1839483e | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Newborn-35|World / Primary Cells by Cluster | 4.03e-05 | 198 | 141 | 6 | de5214a85fe017eb23d4aa8af624464f062ec57e | |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 4.14e-05 | 199 | 141 | 6 | f0b0097df0026496470a80d8cc9375ffd8389b00 | |
| ToppCell | Influenza-Influenza_Severe-Others-RBC|Influenza_Severe / Disease, condition lineage and cell class | 4.14e-05 | 199 | 141 | 6 | da0fec0a492bc3827d9066d2590bcd466cd45564 | |
| ToppCell | Parenchymal-10x5prime-Endothelial-Endothelia_vascular-VE_pulmonary_arterial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 4.26e-05 | 200 | 141 | 6 | ac6b8bc9998d303f788511b8f111e682ea9f3df8 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 4.26e-05 | 200 | 141 | 6 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 4.26e-05 | 200 | 141 | 6 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | mild-CD163+_Monocytes_(Sample_ID1_d7)|mild / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 4.26e-05 | 200 | 141 | 6 | 99eb02f974ddc8d1882f4a5b34d4503d6ec0a5f5 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW23-Neuronal-Intermediate|GW23 / Sample Type, Dataset, Time_group, and Cell type. | 4.26e-05 | 200 | 141 | 6 | fe772d98c461c973dfc082e1fc50117c27ced804 | |
| ToppCell | Biopsy_IPF-Mesenchymal-Myofibroblasts|Biopsy_IPF / Sample group, Lineage and Cell type | 4.26e-05 | 200 | 141 | 6 | c2c6f687c49ba790174b27c7b8b084af30b34c86 | |
| Drug | 0317956-0000 [391210-11-0]; Up 200; 10uM; MCF7; HT_HG-U133A | 3.49e-06 | 194 | 141 | 9 | 3855_UP | |
| Drug | Flecainide acetate [54143-56-5]; Up 200; 8.4uM; MCF7; HT_HG-U133A | 3.64e-06 | 195 | 141 | 9 | 3843_UP | |
| Drug | Ozagrel hydrochloride [78712-43-3]; Down 200; 15.2uM; MCF7; HT_HG-U133A | 3.64e-06 | 195 | 141 | 9 | 3503_DN | |
| Drug | p-nitrophenylhydrazine | 1.90e-05 | 9 | 141 | 3 | CID000069472 | |
| Drug | 2-ethylhydracrylic acid | 2.70e-05 | 10 | 141 | 3 | CID000188979 | |
| Drug | CP-645525-01 [287190-82-3]; Up 200; 10uM; MCF7; HT_HG-U133A | 2.90e-05 | 194 | 141 | 8 | 7522_UP | |
| Drug | pioglitazone HCl; Up 200; 10uM; MCF7; HT_HG-U133A | 2.90e-05 | 194 | 141 | 8 | 7523_UP | |
| Drug | Hexylcaine hydrochloride [532-76-3]; Down 200; 13.4uM; MCF7; HT_HG-U133A | 2.90e-05 | 194 | 141 | 8 | 3447_DN | |
| Drug | Etidronic acid, disodium salt [7414-83-7]; Down 200; 16uM; MCF7; HT_HG-U133A | 2.90e-05 | 194 | 141 | 8 | 4387_DN | |
| Drug | 2-propylpentanoic acid; Down 200; 200uM; MCF7; HT_HG-U133A | 3.00e-05 | 195 | 141 | 8 | 1639_DN | |
| Drug | Fusaric acid [536-69-6]; Up 200; 22.4uM; PC3; HT_HG-U133A | 3.12e-05 | 196 | 141 | 8 | 3986_UP | |
| Drug | (+,-)-Synephrine [94-07-5]; Down 200; 24uM; MCF7; HT_HG-U133A | 3.12e-05 | 196 | 141 | 8 | 6798_DN | |
| Drug | Estropipate [7280-37-7]; Down 200; 9.2uM; HL60; HT_HG-U133A | 3.12e-05 | 196 | 141 | 8 | 2506_DN | |
| Drug | CGX 0596987; Down 200; 20uM; MCF7; HT_HG-U133A | 3.23e-05 | 197 | 141 | 8 | 6412_DN | |
| Drug | (S)-(-)-Cycloserine [339-72-0]; Down 200; 39.2uM; MCF7; HT_HG-U133A | 3.23e-05 | 197 | 141 | 8 | 3870_DN | |
| Drug | Ofloxacin [82419-36-1]; Down 200; 11uM; PC3; HT_HG-U133A | 3.35e-05 | 198 | 141 | 8 | 7372_DN | |
| Drug | Corynanthine hydrochloride [66634-44-4]; Down 200; 10.2uM; MCF7; HT_HG-U133A | 3.35e-05 | 198 | 141 | 8 | 2786_DN | |
| Drug | Etofylline [519-37-9]; Down 200; 17.8uM; MCF7; HT_HG-U133A | 3.35e-05 | 198 | 141 | 8 | 2256_DN | |
| Drug | CP-944629 [668990-94-1]; Up 200; 10uM; PC3; HT_HG-U133A | 3.35e-05 | 198 | 141 | 8 | 7549_UP | |
| Drug | Nalidixic acid sodium salt hydrate; Up 200; 14.6uM; PC3; HT_HG-U133A | 3.47e-05 | 199 | 141 | 8 | 7367_UP | |
| Drug | Khellin [82-02-0]; Up 200; 15.4uM; HL60; HG-U133A | 3.47e-05 | 199 | 141 | 8 | 2004_UP | |
| Drug | 2-propylpentanoic acid; Down 200; 1000uM; HL60; HG-U133A | 3.60e-05 | 200 | 141 | 8 | 409_DN | |
| Drug | AC1NAQHG | 3.81e-05 | 2 | 141 | 2 | CID004481062 | |
| Drug | Maoba | 3.81e-05 | 2 | 141 | 2 | CID000476290 | |
| Drug | 4-hydroxynonenal | IL12RB1 HYOU1 PARP3 CAT AR SIRT4 GGT1 CCNT1 NFIX AOC3 RP1 ENO1 | 3.82e-05 | 471 | 141 | 12 | CID000001693 |
| Disease | aflatoxins-related hepatocellular carcinoma (biomarker_via_orthology) | 3.46e-06 | 7 | 138 | 3 | DOID:5022 (biomarker_via_orthology) | |
| Disease | alcohol dependence (biomarker_via_orthology) | 5.51e-06 | 8 | 138 | 3 | DOID:0050741 (biomarker_via_orthology) | |
| Disease | Diabetes Mellitus | 1.49e-05 | 32 | 138 | 4 | C0011849 | |
| Disease | Fetal Alcohol Spectrum Disorders | 2.77e-05 | 13 | 138 | 3 | C2985290 | |
| Disease | Fetal Alcohol Syndrome | 6.49e-05 | 17 | 138 | 3 | C0015923 | |
| Disease | Neurodevelopmental Disorders | 7.77e-05 | 93 | 138 | 5 | C1535926 | |
| Disease | Alcoholic Intoxication, Chronic | 2.78e-04 | 268 | 138 | 7 | C0001973 | |
| Disease | stimulant use measurement | 3.01e-04 | 28 | 138 | 3 | EFO_0600076 | |
| Disease | Acute Myeloid Leukemia, M1 | 3.11e-04 | 125 | 138 | 5 | C0026998 | |
| Disease | Acute Myeloid Leukemia (AML-M2) | 3.11e-04 | 125 | 138 | 5 | C1879321 | |
| Disease | Hereditary Diffuse Gastric Cancer | 4.74e-04 | 293 | 138 | 7 | C1708349 | |
| Disease | Colorectal Carcinoma | CHL1 DPEP1 ACACA ARFGEF1 DSCAML1 KMT2C DLC1 PTPRD KCNA10 ZKSCAN3 CDH5 | 4.79e-04 | 702 | 138 | 11 | C0009402 |
| Disease | Stomach Neoplasms | 5.14e-04 | 297 | 138 | 7 | C0038356 | |
| Disease | Malignant neoplasm of stomach | 5.46e-04 | 300 | 138 | 7 | C0024623 | |
| Disease | lysosomal Pro-X carboxypeptidase measurement | 5.97e-04 | 8 | 138 | 2 | EFO_0801777 | |
| Disease | cataract (implicated_via_orthology) | 7.49e-04 | 38 | 138 | 3 | DOID:83 (implicated_via_orthology) | |
| Disease | creatinine measurement | DPEP1 DSCAM LHX3 AR NPLOC4 USP20 CEMIP STAC2 ACSM3 DLC1 PRRC2C DOCK7 SUFU | 8.19e-04 | 995 | 138 | 13 | EFO_0004518 |
| Disease | forced expiratory volume, body mass index | 1.16e-03 | 11 | 138 | 2 | EFO_0004314, EFO_0004340 | |
| Disease | Leukemia, Myelocytic, Acute | 1.35e-03 | 173 | 138 | 5 | C0023467 | |
| Disease | Malignant neoplasm of breast | AMFR MAN2C1 STXBP4 CAT AR MOSPD1 GTF2A1 PTPRD OTOF NISCH ENO1 CDH5 VPS13B | 1.63e-03 | 1074 | 138 | 13 | C0006142 |
| Disease | Carcinoma, Granular Cell | 2.19e-03 | 116 | 138 | 4 | C0205644 | |
| Disease | Adenocarcinoma, Tubular | 2.19e-03 | 116 | 138 | 4 | C0205645 | |
| Disease | Adenocarcinoma, Oxyphilic | 2.19e-03 | 116 | 138 | 4 | C0205642 | |
| Disease | Carcinoma, Cribriform | 2.19e-03 | 116 | 138 | 4 | C0205643 | |
| Disease | Adenocarcinoma, Basal Cell | 2.19e-03 | 116 | 138 | 4 | C0205641 | |
| Disease | Adenocarcinoma | 2.19e-03 | 116 | 138 | 4 | C0001418 | |
| Disease | Down syndrome (implicated_via_orthology) | 2.19e-03 | 15 | 138 | 2 | DOID:14250 (implicated_via_orthology) | |
| Disease | Muscle hypotonia | 2.82e-03 | 17 | 138 | 2 | C0026827 | |
| Disease | hypertension (implicated_via_orthology) | 3.12e-03 | 128 | 138 | 4 | DOID:10763 (implicated_via_orthology) | |
| Disease | Mammary Carcinoma, Human | 3.37e-03 | 525 | 138 | 8 | C4704874 | |
| Disease | Mammary Neoplasms, Human | 3.37e-03 | 525 | 138 | 8 | C1257931 | |
| Disease | Mammary Neoplasms | 3.45e-03 | 527 | 138 | 8 | C1458155 | |
| Disease | type 2 diabetes mellitus (is_marker_for) | 3.88e-03 | 136 | 138 | 4 | DOID:9352 (is_marker_for) | |
| Disease | Breast Carcinoma | 3.90e-03 | 538 | 138 | 8 | C0678222 | |
| Disease | Benign Neoplasm | 4.02e-03 | 68 | 138 | 3 | C0086692 | |
| Disease | Neoplasms | 4.02e-03 | 68 | 138 | 3 | C0027651 | |
| Disease | Profound Mental Retardation | 4.19e-03 | 139 | 138 | 4 | C0020796 | |
| Disease | Mental Retardation, Psychosocial | 4.19e-03 | 139 | 138 | 4 | C0025363 | |
| Disease | Mental deficiency | 4.19e-03 | 139 | 138 | 4 | C0917816 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| AQPGQVVAPGAVLVR | 96 | Q9Y5B0 | |
| PSAVRGFQPIEIQQV | 266 | O14627 | |
| GPRGIFRVVPQTVLN | 401 | Q96JP9 | |
| PQGVKEVFQLQRPQG | 6 | Q6P047 | |
| QQGVLREEPPGTFSV | 701 | Q9UJX6 | |
| VGNNTPIFFIRDPIL | 146 | P04040 | |
| ICRPGSVIGPQQQFL | 346 | O60729 | |
| GVVFQISQPPEQELG | 1831 | Q9Y6D6 | |
| QTQPLGTIVNGLFVV | 256 | O14862 | |
| RQVFQVLEEQPPGTL | 46 | Q6V0I7 | |
| VGVRPGDAIQVQPLV | 121 | Q8NB90 | |
| SPVEVKPGNVRNIIQ | 556 | O15085 | |
| EGVQLNLSFIRPPEN | 676 | O75843 | |
| QLTPQIPLTGFVARV | 371 | Q8IZP0 | |
| PNLFRQVQAEVPGSP | 331 | Q13085 | |
| QGVQPTQPTAFEFVR | 671 | O60563 | |
| QEEIFGPILPIVNVQ | 251 | P48448 | |
| VPEIQALVQTLQGPF | 86 | Q96HY7 | |
| PPAGNRAQVIINITD | 351 | P33151 | |
| TLPIGQNFPIRGIQL | 866 | Q8WUJ3 | |
| IPELAARGIIQQVFP | 196 | Q9HCE9 | |
| AIVFFGRQPQPNVSE | 126 | Q16853 | |
| QYQVTVPENVPVGTR | 246 | Q9Y5G6 | |
| AQPGEVQRSLVQPGI | 616 | Q9H0J4 | |
| ELDGQQVVVPQGQPV | 486 | Q9Y6F1 | |
| DNVPVVIGPALRNNT | 571 | Q9HCL0 | |
| PIIPNFVAQGAERVS | 771 | Q9Y5E7 | |
| VTQTRQGFLPPLNVN | 441 | A5PLL1 | |
| LFQPSIQLARQGFPV | 156 | A6NGU5 | |
| GLPIRPEQQAVFFTL | 16 | Q8NGS2 | |
| VVQIVSGFQGARPQP | 131 | Q5VUB5 | |
| VSIGPRDGNFLNIPQ | 481 | Q14938 | |
| ERFLVPPQQIQGSGV | 2496 | Q8NEZ4 | |
| IQTQARLPFNGIIPS | 501 | Q6MZP7 | |
| EPVGFQGCIRQVIIN | 2861 | Q5T1H1 | |
| VIAVNEVGRSQPSQP | 686 | O00533 | |
| PQQLLLFVQSFGIPV | 1241 | Q8N201 | |
| QELARVVQGSPEVPG | 1386 | Q8N201 | |
| EVAPSGQGERVVNVP | 116 | A6ND01 | |
| RNVFVSPIDVGCQPV | 21 | O76014 | |
| DQQAVPDVTRIGPSQ | 1871 | Q2LD37 | |
| SFEGIQLPQVPGRVL | 236 | Q14999 | |
| QEFQVPDVLRGPNTI | 206 | Q6ZU69 | |
| ISQNPFPIENRDVLG | 466 | Q8TAT6 | |
| NGLFVTPVPVLAAQR | 161 | Q8NGI3 | |
| RQPELVEGNLPVFVF | 6 | Q9UJG1 | |
| GAVEQPQPQFISRFL | 371 | Q86SG6 | |
| ALRPVNGVINTLQPV | 541 | Q7Z3B3 | |
| AGPTISPVRQEEVQF | 1856 | P09848 | |
| NDVIPFVRRTVPEGQ | 606 | P50748 | |
| GIPPTQVVRRAQDFV | 96 | Q9UBR4 | |
| VAQFGPQKEPVRQQI | 866 | Q96RT8 | |
| LTENIQRFLPNPAGV | 606 | P00451 | |
| LFQSVREVIQNPGPR | 26 | P10275 | |
| IVPNGITLPVDFQGR | 136 | P31943 | |
| SINEQEGIATVRFPP | 1766 | Q9Y4D8 | |
| QEPEQFPLVQGVAIG | 46 | P29728 | |
| RPRDQAVFPQNGLVV | 621 | Q14764 | |
| LPVNNIFQQISPVVG | 316 | Q9Y2X0 | |
| INDNPPVFRGREQII | 126 | Q9Y5I3 | |
| AFLPIIPNTQRGQLE | 101 | Q96LP2 | |
| VQTGFVSPIRPLGLQ | 126 | Q0D2I5 | |
| QQVQPRFDGVPQRFD | 1081 | O94913 | |
| LQFQVTARDAGVPPL | 531 | Q9UN74 | |
| PEPVVLNEGNQRVII | 76 | Q16322 | |
| ANGAPPRVLQQLVEE | 211 | Q7Z6L0 | |
| SEVILPVPAFNVING | 141 | P06733 | |
| FERVPGPVQQALQSA | 356 | Q9Y4L1 | |
| IRPPVIAGQIVNLGQ | 801 | Q96N67 | |
| PNAFDGPITITIVNR | 136 | P16070 | |
| VPVLARNIPGNAAVV | 266 | Q96MS3 | |
| VRVPPRFVVQPNNQD | 686 | Q8TD84 | |
| QREGVLEPNPVRNFL | 181 | Q9Y3X0 | |
| FRINPDGSQSVVEVP | 56 | Q9Y2B0 | |
| PGTVQGVVRFLQLTP | 96 | O14618 | |
| VGGPLQNIDFTQRPF | 1641 | Q5VZ89 | |
| ENVQEIPVFGIVPAI | 576 | Q13443 | |
| DVQLPVITLNFVPGV | 71 | Q8NFQ5 | |
| PPQPQVRFSVEQLGQ | 236 | P42701 | |
| KVPVPRGADQVVQQE | 171 | Q8NA82 | |
| LLPQQPVFVVQETDG | 671 | Q9NTJ4 | |
| PVSIEPRINVGSRFQ | 716 | Q6PJG2 | |
| VGPQGDPRVFQLQQS | 601 | Q7Z6J4 | |
| QENEPTVGVIPRVIQ | 106 | O95239 | |
| QPAGQVAVLPEVQVT | 3606 | Q03164 | |
| GNVAVRLFSLQAPVP | 476 | Q8NFI3 | |
| IRPFPGLVINNQLVD | 941 | P78347 | |
| EPQSQGLSPFGQRVV | 186 | P16444 | |
| VQDVARVLGFQNPTP | 116 | Q8ND90 | |
| VFQRIPGVDPENVFI | 81 | Q08AI6 | |
| PQVNISVQGEVPRTL | 136 | P34925 | |
| NPTLAQIPVVFRLAG | 381 | Q9BQ95 | |
| LFQPSIQLARQGFPV | 156 | P36268 | |
| FQGIPSNDPINVLVR | 1481 | Q9HC10 | |
| FRVVAVNNIGRGPPS | 391 | P23468 | |
| PQFGGVRVVVNPRSF | 46 | P56715 | |
| VPQFQPIALNGRIQV | 731 | O60469 | |
| TGDVVVQAPTQVPGF | 26 | P15151 | |
| INPVPGQAITQIFAV | 361 | Q8IZC4 | |
| LSPFQVVVIPVGSEQ | 611 | Q9BW92 | |
| TFLFQGQPVVNRPLS | 201 | Q15628 | |
| LRQRFPEIPEGVVSQ | 16 | Q8N5C8 | |
| VDAGLSPAQFQVRPI | 166 | Q6ZSG1 | |
| TEVVVPFNQIPGNSL | 326 | P25105 | |
| FRIEPGVSVSLVNPQ | 1061 | Q9P2J5 | |
| QPIFITTQGFPVRNV | 146 | Q7Z3K3 | |
| VQQGQTVRPITLVPA | 176 | Q7Z3K3 | |
| QVSQPFRGLIPAGTQ | 2631 | Q9Y520 | |
| AINRAGIVQEDVQPP | 41 | Q8N5G0 | |
| QAVPQGAETPRPLFQ | 326 | Q2M3G4 | |
| TPRGVLQERFQVLNP | 176 | Q9Y6E7 | |
| IDFNQPLVITRITPG | 21 | Q53GG5 | |
| VEPVAQGIVSQQLPA | 806 | Q15714 | |
| NIFVGQTESPLLVRP | 336 | Q9HAS3 | |
| VPKQEGRTVVVVNNP | 1001 | Q6ZRS2 | |
| RNEGPLVYIQEIIPG | 41 | Q6ZWJ1 | |
| FGVPLTVNVQRTGQP | 1076 | Q96QB1 | |
| SQVQEPGGVPQVFLT | 446 | P11831 | |
| IRIQPPSAQLEVQAG | 2861 | Q8IVF2 | |
| DNILEGRIQVPFPTQ | 491 | Q9UKV5 | |
| QEGDIGIQVLPNRPF | 421 | Q53FZ2 | |
| QTGVIIQPQQILFTG | 216 | P52655 | |
| VRQRNPQELGVFAPT | 631 | Q8WYP3 | |
| VNIAQQVVIGTPQRP | 56 | Q14186 | |
| LILIPNGVQIFFVNP | 221 | Q8N0X7 | |
| RQVFSVAPPFEVNGL | 661 | Q5TCY1 | |
| LRIPGTQAEFQTPIA | 211 | Q9NU63 | |
| FPANFVQRVRPGENV | 341 | Q6ZMT1 | |
| RAFQEQALPVLQAGP | 191 | Q6NSZ9 | |
| VQVVPGSGQIIFLPF | 576 | Q9Y2I1 | |
| QPVQTPFGVVTFLQI | 186 | Q9UMX1 | |
| VTEIFSQIPNNGLPR | 396 | O43847 | |
| DIPPIFGVQQQVARQ | 2446 | Q9P273 | |
| GLPRNTVVLFVPQQE | 31 | Q9UJZ1 | |
| IAIRQSVAQPLGPEN | 886 | Q9Y2K6 | |
| IIIPPNFQEAFQIGI | 3016 | Q7Z7G8 | |
| GSQPLQDRVLQVPVL | 176 | Q9BRR0 | |
| PRFPTLGGRVVNVAQ | 196 | Q9H598 | |
| PGLSQRQFEIVSNGP | 106 | P35442 | |
| GDFRVPQILQPFING | 211 | O75845 | |
| LERNIVFGINPGVAP | 851 | Q08AF3 | |
| PQVVFSDGQQRPVDP | 1456 | Q562E7 | |
| IISGLFPVQQQIAPS | 936 | Q9BVV6 | |
| LFQPSIQLARQGFPV | 156 | P19440 | |
| IVQPENNRPPVAVAG | 616 | Q5VV43 | |
| DIGPLFQTPREVAQQ | 646 | P22033 | |
| QFLGALPPEIQARVQ | 91 | P28698 |